HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 16-NOV-15 5ESM TITLE SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I TITLE 2 MUTANT COMPLEXED WITH FLUCONAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.14.13.70; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE (STRAIN YJM789); SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 307796; SOURCE 5 STRAIN: YJM789; SOURCE 6 GENE: ERG11, SCY_2394; SOURCE 7 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: AD2DELTA KEYWDS CYP51, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.SAGATOVA,M.V.KENIYA,R.K.WILSON,M.SABHERWAL,J.D.A.TYNDALL,B.C.MONK REVDAT 4 27-SEP-23 5ESM 1 REMARK REVDAT 3 01-JAN-20 5ESM 1 REMARK REVDAT 2 20-SEP-17 5ESM 1 REMARK REVDAT 1 23-NOV-16 5ESM 0 JRNL AUTH A.SAGATOVA,M.V.KENIYA,R.K.WILSON,M.SABHERWAL,J.D.A.TYNDALL, JRNL AUTH 2 B.C.MONK JRNL TITL STRUCTURES OF LANOSTEROL 14-ALPHA DEMETHYLASE MUTANTS. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.C.MONK,T.M.TOMASIAK,M.V.KENIYA,F.U.HUSCHMANN,J.D.TYNDALL, REMARK 1 AUTH 2 J.D.O'CONNELL,R.D.CANNON,J.G.MCDONALD,A.RODRIGUEZ, REMARK 1 AUTH 3 J.S.FINER-MOORE,R.M.STROUD REMARK 1 TITL ARCHITECTURE OF A SINGLE MEMBRANE SPANNING CYTOCHROME P450 REMARK 1 TITL 2 SUGGESTS CONSTRAINTS THAT ORIENT THE CATALYTIC DOMAIN REMARK 1 TITL 3 RELATIVE TO A BILAYER. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 111 3865 2014 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ESSN 1091-6490 REMARK 1 PMID 24613931 REMARK 1 DOI 10.1073/PNAS.1324245111 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.A.SAGATOVA,M.V.KENIYA,R.K.WILSON,B.C.MONK,J.D.TYNDALL REMARK 1 TITL STRUCTURAL INSIGHTS INTO BINDING OF THE ANTIFUNGAL DRUG REMARK 1 TITL 2 FLUCONAZOLE TO SACCHAROMYCES CEREVISIAE LANOSTEROL REMARK 1 TITL 3 14ALPHA-DEMETHYLASE. REMARK 1 REF ANTIMICROB. AGENTS V. 59 4982 2015 REMARK 1 REF 2 CHEMOTHER. REMARK 1 REFN ESSN 1098-6596 REMARK 1 PMID 26055382 REMARK 1 DOI 10.1128/AAC.00925-15 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 57073 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2874 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.9135 - 5.5069 0.97 2612 136 0.1928 0.2285 REMARK 3 2 5.5069 - 4.3754 1.00 2631 134 0.1725 0.1921 REMARK 3 3 4.3754 - 3.8236 1.00 2596 156 0.1754 0.2039 REMARK 3 4 3.8236 - 3.4746 0.99 2593 138 0.1904 0.2107 REMARK 3 5 3.4746 - 3.2258 1.00 2587 143 0.2020 0.2618 REMARK 3 6 3.2258 - 3.0358 1.00 2592 138 0.2031 0.2060 REMARK 3 7 3.0358 - 2.8839 1.00 2576 150 0.1996 0.2316 REMARK 3 8 2.8839 - 2.7585 0.99 2584 131 0.2044 0.2341 REMARK 3 9 2.7585 - 2.6524 1.00 2569 133 0.1983 0.2526 REMARK 3 10 2.6524 - 2.5609 0.99 2590 125 0.2028 0.2251 REMARK 3 11 2.5609 - 2.4808 1.00 2566 134 0.1967 0.2206 REMARK 3 12 2.4808 - 2.4100 1.00 2577 137 0.2032 0.2295 REMARK 3 13 2.4100 - 2.3465 1.00 2596 111 0.2131 0.2706 REMARK 3 14 2.3465 - 2.2893 1.00 2572 147 0.2249 0.2685 REMARK 3 15 2.2893 - 2.2373 0.99 2561 134 0.2365 0.2613 REMARK 3 16 2.2373 - 2.1897 1.00 2538 153 0.2407 0.3130 REMARK 3 17 2.1897 - 2.1459 1.00 2600 137 0.2596 0.2811 REMARK 3 18 2.1459 - 2.1054 1.00 2574 142 0.2751 0.2826 REMARK 3 19 2.1054 - 2.0678 1.00 2557 135 0.2936 0.3447 REMARK 3 20 2.0678 - 2.0328 1.00 2546 122 0.3285 0.3363 REMARK 3 21 2.0328 - 2.0000 1.00 2582 138 0.3464 0.3754 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4466 REMARK 3 ANGLE : 0.803 6063 REMARK 3 CHIRALITY : 0.030 640 REMARK 3 PLANARITY : 0.003 784 REMARK 3 DIHEDRAL : 13.022 1659 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ESM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215433. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 9.3-9.55 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57073 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 51.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.61700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4LXJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 45% PEG-400, 0.1 M GLYCINE, PH 9.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.82000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 LYS A 5 REMARK 465 SER A 6 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 465 HIS A 537 REMARK 465 HIS A 538 REMARK 465 HIS A 539 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 65 -49.26 68.90 REMARK 500 ILE A 139 -92.91 57.89 REMARK 500 ASP A 141 53.76 -106.65 REMARK 500 LEU A 158 57.37 -113.87 REMARK 500 PHE A 184 -77.71 -122.57 REMARK 500 PHE A 243 76.10 -115.68 REMARK 500 LEU A 248 -169.31 -120.97 REMARK 500 ASP A 277 53.47 -98.85 REMARK 500 GLN A 279 -140.86 -105.64 REMARK 500 ASN A 290 81.16 -150.22 REMARK 500 SER A 291 35.11 -156.15 REMARK 500 MET A 363 72.36 -117.36 REMARK 500 ASP A 434 53.39 -173.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 470 SG REMARK 620 2 HEM A 601 NA 98.0 REMARK 620 3 HEM A 601 NB 91.1 87.6 REMARK 620 4 HEM A 601 NC 88.1 173.5 89.9 REMARK 620 5 HEM A 601 ND 95.6 90.9 173.4 90.9 REMARK 620 6 TPF A 602 N5 177.0 83.8 86.6 90.1 86.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TPF A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ESE RELATED DB: PDB REMARK 900 RELATED ID: 5ESF RELATED DB: PDB REMARK 900 RELATED ID: 5ESG RELATED DB: PDB REMARK 900 RELATED ID: 5ESL RELATED DB: PDB REMARK 900 RELATED ID: 5ESM RELATED DB: PDB REMARK 900 RELATED ID: 5ESN RELATED DB: PDB REMARK 900 RELATED ID: 5ESH RELATED DB: PDB REMARK 900 RELATED ID: 5ESI RELATED DB: PDB REMARK 900 RELATED ID: 5ESK RELATED DB: PDB DBREF 5ESM A 1 530 UNP A6ZSR0 A6ZSR0_YEAS7 1 530 SEQADV 5ESM ILE A 322 UNP A6ZSR0 THR 322 ENGINEERED MUTATION SEQADV 5ESM GLY A 531 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM GLY A 532 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM ARG A 533 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 534 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 535 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 536 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 537 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 538 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESM HIS A 539 UNP A6ZSR0 EXPRESSION TAG SEQRES 1 A 539 MET SER ALA THR LYS SER ILE VAL GLY GLU ALA LEU GLU SEQRES 2 A 539 TYR VAL ASN ILE GLY LEU SER HIS PHE LEU ALA LEU PRO SEQRES 3 A 539 LEU ALA GLN ARG ILE SER LEU ILE ILE ILE ILE PRO PHE SEQRES 4 A 539 ILE TYR ASN ILE VAL TRP GLN LEU LEU TYR SER LEU ARG SEQRES 5 A 539 LYS ASP ARG PRO PRO LEU VAL PHE TYR TRP ILE PRO TRP SEQRES 6 A 539 VAL GLY SER ALA VAL VAL TYR GLY MET LYS PRO TYR GLU SEQRES 7 A 539 PHE PHE GLU GLU CYS GLN LYS LYS TYR GLY ASP ILE PHE SEQRES 8 A 539 SER PHE VAL LEU LEU GLY ARG VAL MET THR VAL TYR LEU SEQRES 9 A 539 GLY PRO LYS GLY HIS GLU PHE VAL PHE ASN ALA LYS LEU SEQRES 10 A 539 ALA ASP VAL SER ALA GLU ALA ALA TYR ALA HIS LEU THR SEQRES 11 A 539 THR PRO VAL PHE GLY LYS GLY VAL ILE TYR ASP CYS PRO SEQRES 12 A 539 ASN SER ARG LEU MET GLU GLN LYS LYS PHE VAL LYS GLY SEQRES 13 A 539 ALA LEU THR LYS GLU ALA PHE LYS SER TYR VAL PRO LEU SEQRES 14 A 539 ILE ALA GLU GLU VAL TYR LYS TYR PHE ARG ASP SER LYS SEQRES 15 A 539 ASN PHE ARG LEU ASN GLU ARG THR THR GLY THR ILE ASP SEQRES 16 A 539 VAL MET VAL THR GLN PRO GLU MET THR ILE PHE THR ALA SEQRES 17 A 539 SER ARG SER LEU LEU GLY LYS GLU MET ARG ALA LYS LEU SEQRES 18 A 539 ASP THR ASP PHE ALA TYR LEU TYR SER ASP LEU ASP LYS SEQRES 19 A 539 GLY PHE THR PRO ILE ASN PHE VAL PHE PRO ASN LEU PRO SEQRES 20 A 539 LEU GLU HIS TYR ARG LYS ARG ASP HIS ALA GLN LYS ALA SEQRES 21 A 539 ILE SER GLY THR TYR MET SER LEU ILE LYS GLU ARG ARG SEQRES 22 A 539 LYS ASN ASN ASP ILE GLN ASP ARG ASP LEU ILE ASP SER SEQRES 23 A 539 LEU MET LYS ASN SER THR TYR LYS ASP GLY VAL LYS MET SEQRES 24 A 539 THR ASP GLN GLU ILE ALA ASN LEU LEU ILE GLY VAL LEU SEQRES 25 A 539 MET GLY GLY GLN HIS THR SER ALA ALA ILE SER ALA TRP SEQRES 26 A 539 ILE LEU LEU HIS LEU ALA GLU ARG PRO ASP VAL GLN GLN SEQRES 27 A 539 GLU LEU TYR GLU GLU GLN MET ARG VAL LEU ASP GLY GLY SEQRES 28 A 539 LYS LYS GLU LEU THR TYR ASP LEU LEU GLN GLU MET PRO SEQRES 29 A 539 LEU LEU ASN GLN THR ILE LYS GLU THR LEU ARG MET HIS SEQRES 30 A 539 HIS PRO LEU HIS SER LEU PHE ARG LYS VAL MET LYS ASP SEQRES 31 A 539 MET HIS VAL PRO ASN THR SER TYR VAL ILE PRO ALA GLY SEQRES 32 A 539 TYR HIS VAL LEU VAL SER PRO GLY TYR THR HIS LEU ARG SEQRES 33 A 539 ASP GLU TYR PHE PRO ASN ALA HIS GLN PHE ASN ILE HIS SEQRES 34 A 539 ARG TRP ASN ASN ASP SER ALA SER SER TYR SER VAL GLY SEQRES 35 A 539 GLU GLU VAL ASP TYR GLY PHE GLY ALA ILE SER LYS GLY SEQRES 36 A 539 VAL SER SER PRO TYR LEU PRO PHE GLY GLY GLY ARG HIS SEQRES 37 A 539 ARG CYS ILE GLY GLU HIS PHE ALA TYR CYS GLN LEU GLY SEQRES 38 A 539 VAL LEU MET SER ILE PHE ILE ARG THR LEU LYS TRP HIS SEQRES 39 A 539 TYR PRO GLU GLY LYS THR VAL PRO PRO PRO ASP PHE THR SEQRES 40 A 539 SER MET VAL THR LEU PRO THR GLY PRO ALA LYS ILE ILE SEQRES 41 A 539 TRP GLU LYS ARG ASN PRO GLU GLN LYS ILE GLY GLY ARG SEQRES 42 A 539 HIS HIS HIS HIS HIS HIS HET HEM A 601 43 HET TPF A 602 22 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM TPF 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL) HETNAM 2 TPF PROPAN-2-OL HETSYN HEM HEME HETSYN TPF FLUCONAZOLE; ALPHA-(2,4-DIFLUOROPHENYL)-ALPHA-(1H-1,2, HETSYN 2 TPF 4-TRIAZOLE-1-YLMETHYL)-1H-1,2,4-TRIAZOLE-1-ETHANOL; HETSYN 3 TPF ELAZOR; TRIFLUCAN; BIOZOLENE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 TPF C13 H12 F2 N6 O FORMUL 4 HOH *202(H2 O) HELIX 1 AA1 VAL A 8 ALA A 24 1 17 HELIX 2 AA2 PRO A 26 SER A 50 1 25 HELIX 3 AA3 SER A 68 LYS A 75 1 8 HELIX 4 AA4 LYS A 75 GLY A 88 1 14 HELIX 5 AA5 GLY A 105 ASN A 114 1 10 HELIX 6 AA6 ALA A 122 GLY A 135 1 14 HELIX 7 AA7 PRO A 143 GLY A 156 1 14 HELIX 8 AA8 THR A 159 SER A 181 1 23 HELIX 9 AA9 VAL A 196 LEU A 213 1 18 HELIX 10 AB1 GLY A 214 LEU A 221 1 8 HELIX 11 AB2 ASP A 222 ASP A 224 5 3 HELIX 12 AB3 PHE A 225 PHE A 236 1 12 HELIX 13 AB4 THR A 237 VAL A 242 5 6 HELIX 14 AB5 LEU A 248 ASN A 275 1 28 HELIX 15 AB6 ASP A 282 ASN A 290 1 9 HELIX 16 AB7 THR A 300 GLU A 332 1 33 HELIX 17 AB8 ARG A 333 LEU A 348 1 16 HELIX 18 AB9 THR A 356 GLN A 361 1 6 HELIX 19 AC1 MET A 363 HIS A 377 1 15 HELIX 20 AC2 SER A 409 HIS A 414 1 6 HELIX 21 AC3 ASN A 427 ASN A 432 5 6 HELIX 22 AC4 GLY A 465 ARG A 469 5 5 HELIX 23 AC5 GLY A 472 THR A 490 1 19 SHEET 1 AA1 5 ILE A 90 LEU A 95 0 SHEET 2 AA1 5 ARG A 98 TYR A 103 -1 O VAL A 102 N PHE A 91 SHEET 3 AA1 5 HIS A 405 VAL A 408 1 O HIS A 405 N THR A 101 SHEET 4 AA1 5 LEU A 383 VAL A 387 -1 N ARG A 385 O VAL A 406 SHEET 5 AA1 5 VAL A 120 SER A 121 -1 N SER A 121 O LYS A 386 SHEET 1 AA2 3 THR A 191 ASP A 195 0 SHEET 2 AA2 3 LYS A 518 LYS A 523 -1 O ILE A 519 N ILE A 194 SHEET 3 AA2 3 LEU A 491 HIS A 494 -1 N HIS A 494 O ILE A 520 SHEET 1 AA3 2 MET A 391 HIS A 392 0 SHEET 2 AA3 2 VAL A 399 ILE A 400 -1 O ILE A 400 N MET A 391 SHEET 1 AA4 2 GLU A 444 ASP A 446 0 SHEET 2 AA4 2 ALA A 451 SER A 453 -1 O ILE A 452 N VAL A 445 SHEET 1 AA5 2 PRO A 504 ASP A 505 0 SHEET 2 AA5 2 LEU A 512 PRO A 513 -1 O LEU A 512 N ASP A 505 LINK SG CYS A 470 FE HEM A 601 1555 1555 2.33 LINK FE HEM A 601 N5 TPF A 602 1555 1555 2.14 CISPEP 1 GLY A 515 PRO A 516 0 -2.15 SITE 1 AC1 21 PHE A 113 TYR A 140 LEU A 147 LYS A 151 SITE 2 AC1 21 VAL A 311 GLY A 315 THR A 318 LEU A 374 SITE 3 AC1 21 PRO A 379 ARG A 385 PRO A 462 PHE A 463 SITE 4 AC1 21 GLY A 464 HIS A 468 CYS A 470 ILE A 471 SITE 5 AC1 21 GLY A 472 ALA A 476 TPF A 602 HOH A 713 SITE 6 AC1 21 HOH A 767 SITE 1 AC2 10 TYR A 126 PHE A 134 ILE A 139 PHE A 236 SITE 2 AC2 10 GLY A 310 GLY A 314 LEU A 380 HEM A 601 SITE 3 AC2 10 HOH A 713 HOH A 744 CRYST1 79.370 67.640 81.040 90.00 99.77 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012599 0.000000 0.002169 0.00000 SCALE2 0.000000 0.014784 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012521 0.00000